Genelux GNLX
NASDAQ GNLX
$2.75 +0.01 (+0.36%)
As of: Aug 21, 2026 · 11:54 AM EDT

Genelux (GNLX) Net Margin (QoQ) (2022 - 2023)

Genelux (GNLX) Net Margin (QoQ) (2022 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.90 Bn 132.05 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.70 Bn 78.71 Bn 3.93 Bn
3 Argenx Se 65.73 Bn 60.55 Bn 1.37 Bn
4 Moderna 58.33 Bn 53.19 Bn 52.00 Mn
5 BeOne Medicines 42.16 Bn 37.07 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.72 Bn 28.42 Bn 992.69 Mn
7 BioNTech SE 28.27 Bn 9.88 Bn 668.28 Mn
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn
9 Royalty Pharma 27.25 Bn 26.41 Bn -
10 Genelux 121.42 Mn 121.42 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 -566,286.00
Dec 31, 2022 -1,236.00